N22907
yx66f02.s1 Soares melanocyte 2NbHM Homo sapiens cDNA clone IMAGE:266715 3' similar to gb:X57138_rna1 HISTONE H2B.2 (HUMAN), mRNA sequence.
544
mRNA
Homo sapiens
FU797388
JP 2009528046-A/22905: Method for identifying useful proteins of brewery yeast.
25
DNA
Saccharomyces pastorianus
DM797365
JP 2014068652-A/22907: NEISSERIAL ANTIGENIC PEPTIDES.
8
PRT
Neisseria
LV568729
JP 2017029159-A/22907: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
PA338555
JP 2021522188-A/22907: Compositions and Methods for Multiplexed Tumor Vaccination with Endogenous Gene Activation.
20
DNA
synthetic construct
PA393630
JP 2021533803-A/22713: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE.
26
DNA
Homo sapiens
LF830063
JP 2016528161-A/22896: COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS.
18
RNA
synthetic construct
DJ152287
JP 2007228956-A/22905: Method for identification of useful proteins derived from brewery yeast.
25
DNA
Saccharomyces pastorianus
PA527391
JP 2022502046-A/10173: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY.
21
DNA
synthetic construct
MC551407
JP 2019525738-A/22907: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES.
16
PRT
synthetic construct
OG752426
JP 2021120380-A/22907: CANCER NEOEPITOPES.
9
PRT
Homo sapiens
PD710821
JP 2021530475-A/22903: De novo Design of Protein Switches.
60
PRT
synthetic construct
HW187935
JP 2013102767-A/22859: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
HV879448
JP 2010507387-A/22859: Novel siRNAs and Methods of Use Thereof.
21
RNA
synthetic construct
HZ527688
JP 2016501039-A/22907: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
LX120523
JP 2017506877-A/22905: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes.
16
DNA
synthetic construct
DD549510
JP 2004508801-A/22907: NEISSERIAL ANTIGENIC PEPTIDES.
8
PRT
Neisseria
DJ526707
JP 2010517930-A/22907: Method of constructing and screening libraries of peptide structures.
30
PRT
synthetic construct
DM759601
JP 2014079248-A/22907: NEISSERIAL ANTIGENIC PEPTIDES.
8
PRT
Neisseria
MC906645
JP 2018536623-A/22907: PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF.
32
PRT
synthetic construct
OG507093
JP 2018534252-A/22907: PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF.
35
PRT
synthetic construct
OG659293
JP 2021500321-A/22907: METHODS AND COMPOSITIONS FOR INHIBITING ADAM10 BIOLOGICAL ACTIVITIES.
189
PRT
synthetic construct
DL031921
JP 2005512499-A/22907: Diagnosis of existing illnesses or that praedisposition for determined illnesses.
805
DNA
synthetic construct
HW858131
JP 2015051004-A/22859: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
DL613509
JP 2011092200-A/22907: NEISSERIAL ANTIGENIC PEPTIDES.
8
PRT
Neisseria
MC775017
JP 2018525446-A/22907: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
31
PRT
synthetic construct
LF682128
JP 2016521556-A/22907: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION.
15
DNA
Homo sapiens
MC164751
JP 2019500349-A/22907: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES.
18
RNA
synthetic construct
MD269040
JP 2020517247-A/22907: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof.
20
DNA
synthetic construct
MD755149
JP 2019507579-A/22907: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY.
20
DNA
synthetic construct
